MedApp S.A. (WSE:MDA)

MedApp Statistics

Total Valuation

MedApp has a market cap or net worth of PLN 52.53 million. The enterprise value is 56.51 million.

Market Cap	52.53M
Enterprise Value	56.51M

Important Dates

The last earnings date was Friday, May 15, 2026.

Earnings Date	May 15, 2026
Ex-Dividend Date	n/a

Share Statistics

MedApp has 250.13 million shares outstanding.

Current Share Class	250.13M
Shares Outstanding	250.13M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	120.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.55
PB Ratio	2.04
P/TBV Ratio	3.73
P/FCF Ratio	84.31
P/OCF Ratio	21.04
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 57.20, with an EV/FCF ratio of 90.71.

EV / Earnings	-47.73
EV / Sales	10.27
EV / EBITDA	57.20
EV / EBIT	n/a
EV / FCF	90.71

Financial Position

The company has a current ratio of 0.76, with a Debt / Equity ratio of 0.05.

Current Ratio	0.76
Quick Ratio	0.19
Debt / Equity	0.05
Debt / EBITDA	1.37
Debt / FCF	2.17
Interest Coverage	-0.61

Financial Efficiency

Return on equity (ROE) is -3.95% and return on invested capital (ROIC) is -1.45%.

Return on Equity (ROE)	-3.95%
Return on Assets (ROA)	-0.62%
Return on Invested Capital (ROIC)	-1.45%
Return on Capital Employed (ROCE)	-1.54%
Weighted Average Cost of Capital (WACC)	10.78%
Revenue Per Employee	687,625
Profits Per Employee	-148,000
Employee Count	8
Asset Turnover	0.14
Inventory Turnover	0.42

Taxes

In the past 12 months, MedApp has paid 26,000 in taxes.

Income Tax	26,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +40.00% in the last 52 weeks. The beta is 1.06, so MedApp's price volatility has been similar to the market average.

Beta (5Y)	1.06
52-Week Price Change	+40.00%
50-Day Moving Average	0.23
200-Day Moving Average	0.18
Relative Strength Index (RSI)	43.75
Average Volume (20 Days)	101,644

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MedApp had revenue of PLN 5.50 million and -1.18 million in losses.

Revenue	5.50M
Gross Profit	2.20M
Operating Income	-399,000
Pretax Income	-1.04M
Net Income	-1.18M
EBITDA	988,000
EBIT	-399,000
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has 253,000 in cash and 1.35 million in debt, with a net cash position of -1.10 million or -0.00 per share.

Cash & Cash Equivalents	253,000
Total Debt	1.35M
Net Cash	-1.10M
Net Cash Per Share	-0.00
Equity (Book Value)	25.70M
Book Value Per Share	n/a
Working Capital	-3.29M

Cash Flow

In the last 12 months, operating cash flow was 2.50 million and capital expenditures -1.87 million, giving a free cash flow of 623,000.

Operating Cash Flow	2.50M
Capital Expenditures	-1.87M
Depreciation & Amortization	1.39M
Net Borrowing	-309,000
Free Cash Flow	623,000
FCF Per Share	0.00

Margins

Gross margin is 39.96%, with operating and profit margins of -7.25% and -21.52%.

Gross Margin	39.96%
Operating Margin	-7.25%
Pretax Margin	-18.94%
Profit Margin	-21.52%
EBITDA Margin	17.96%
EBIT Margin	-7.25%
FCF Margin	11.33%

Dividends & Yields

MedApp does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-2.25%
FCF Yield	1.19%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2